These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 6380254

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced cholinergic cutaneous vasodilation in Raynaud's phenomenon.
    Khan F, Coffman JD.
    Circulation; 1994 Mar; 89(3):1183-8. PubMed ID: 8124805
    [Abstract] [Full Text] [Related]

  • 4. Nifedipine as a therapeutic modality for Raynaud's phenomenon.
    Winston EL, Pariser KM, Miller KB, Salem DN, Creager MA.
    Arthritis Rheum; 1983 Oct; 26(10):1177-80. PubMed ID: 6626276
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon.
    Ettinger WH, Wise RA, Schaffhauser D, Wigley FM.
    Am J Med; 1984 Sep; 77(3):451-6. PubMed ID: 6540986
    [Abstract] [Full Text] [Related]

  • 9. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
    Kallenberg CG, Wouda AA, Kuitert JJ, Tijssen J, Wesseling H.
    J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Digital vasodilatation during mental stress in patients with Raynaud's disease.
    Halperin JL, Cohen RA, Coffman JD.
    Cardiovasc Res; 1983 Nov; 17(11):671-7. PubMed ID: 6652643
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud's disease.
    Weber A, Bounameaux H.
    J Cardiovasc Pharmacol; 1990 May; 15(5):853-5. PubMed ID: 1692948
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon.
    Fisher J, Mack RJ, Likier HM, Schiff AN, Borer JS.
    Chest; 1987 Sep; 92(3):400-5. PubMed ID: 3622018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.